A person holding a Hound Labs device displaying a "pass" result for a cannabis breathalyzer test.

Cannabis Breathalyzer System

Client

Hound Labs

Challenge

Hound Labs partnered with Triple Ring Technologies to invent a point-of-use breath analyzer to meet the needs of law enforcement agencies across the world and employers in states where recreational marijuana use is legal. Starting from a napkin sketch, Triple Ring, alongside Hound Labs, created a high-sensitivity portable breathalyzer system tailored to law enforcement and employment settings.  The project included ground-breaking validation, and peer reviewed publication, of ∆-9 THC pharmacodynamics in exhaled breath.

 

Outcomes

Fully functioning prototype systems were created featuring an easy-to-use breath capture device, a control station, and low-cost microfluidic lab-on-a-chip cartridges.  Clinical-grade data were robustly produced at the point-of-need to provide indications of recent marijuana use and possible impairment.

 

Triple Ring Value Proposition

  • Full R&D teams, on demand, flexibly resourced from concept to validation
  • Outsourced Tough Tech product development expertise
  • Deep expertise in biological sciences and bioengineering
  • Extensive intellectual property creation owned outright by client
  • Financial stake and shared-risk engagement models
  • Access to Agility Labs incubation facilities
Four conceptual sketches of the handheld Hound Labs cannabis breathalyzer device with different design features highlighted.
Exploded view diagram showing the components of the Hound Labs handheld cannabis breathalyzer, highlighting its interior parts and mechanical design.

Background

Hound Labs markets a first-in-class system for breath-based assessment of recent marijuana use. The company founders chose Triple Ring as their product development partner for our deep life sciences expertise and for our reputation of helping innovators do the seemingly impossible. In a collaboration that has lasted years, Triple Ring has been a trusted partner demonstrating high degrees of urgency, commitment, and ownership as this cutting-edge startup built products that satisfy critical market needs.

A portable cannabis breathalyzer kit by Hound Labs with carrying case and digital handheld device.
A female doctor discussing medical records with a patient in a clinic.

Transdermal GFR Measurement

Client

MediBeacon

Challenge

MediBeacon required expert assistance to develop a photonics-based transdermal detection technology to monitor intravenously injected fluorescent tracer agents and provide clinically actionable measures of kidney function. MediBeacon has brought combination products into the clinic which match fluorescent tracers with innovative detection systems to provide accurate physiological measurements in real-time. Triple Ring, in collaboration with MediBeacon, designed and delivered a non-invasive, light-based wearable detection system as a critical component of their glomerular filtration rate (GFR) monitoring product. The detectors were designed and developed to meet strict product requirements of sensitivity, accuracy, cost, comfort, and ease of use.

 

Outcomes

Fully integrated wearable GFR detectors were developed under ISO13485 design controls and delivered for critical clinical trials.

 

Triple Ring Value Proposition

  • Highly relevant expertise in light-based tissue analysis
  • Advanced modeling and simulations to speed design process
  • Program structure that included skin in the game
  • Deep experience in meeting critical milestones for venture funding
A product photograph of MediBeacon's white vital signs monitor and sensor attached to a stainless steel pole against a light gray background.
MediBeacon medical sensor device with branding next to a vial of green liquid.

Background

MediBeacon selected Triple Ring as their development partner for our multidisciplinary science and engineering teams. Triple Ring’s industry leading capabilities in biophotonics and combination product development, along with our ability to collaborate closely and share risk, made us an optimal partner for MediBeacon.

A doctor records data in a notebook at a workstation with the MediBeacon system, sensor, and vial of liquid nearby.
Close-up photograph of colorful microplastics on finger tips with gray background.

Ocean Microplastics Monitor

Client

Various

Challenge

Addressing a critical unmet need in environmental sensing, Triple Ring Technologies supported the integration of a fieldable, portable microplastics sensor system. The system enables quantitation of plastic particles in aqueous environmental samples and separates plastics from non-plastics for subsequent polymer identification. Triple Ring experts created an integrated and miniaturized unit that replaced a high-end instrument in a benchtop system. This unit was designed to successfully count microplastics under conditions expected in field use – not only measuring plastic but also working correctly in the presence of interferents, such as air bubbles and non-plastics (biological particles, sand, silt, and other non-organic materials).

 

Outcomes

The resulting system could be deployed beyond the benchtop and provided successful demonstrations to funders and partners as the research group furthers its work on microplastics.

 

Value Propositions

  • Relevant expertise in low-cost, ruggedized life sciences assay platforms
  • Rapid design and development process that met strict timelines for delivery
  • Flexible and highly collaborative design teams that interface seamlessly with research institutes
Comparison of current vs triple ring's microplastic testing methods, highlighting efficiency, cost, and portability differences.

Background

The US Environmental Protection Agency (EPA) saw value in funding the Triple Ring and Woods Hole Oceanographic Institution teams to produce a fieldable microplastics monitoring system. Triple Ring personnel brought previous experience of shipboard microplastic measurement from past collaborations with EPA in the Northwest Hawaiian Islands. Woods Hole scientists invented a novel means of measuring ocean microplastics and Triple Ring provided integration support.

Illustration of real-time microplastics concentration data being transmitted via satellite or cellular tower to a centralized mapping system.
Two researchers in life jackets on a boat testing for microplastics in the surrounding water.

Combining WHOI’s core sensing technology with Triple Ring’s experience in delivering integrated products will significantly move the needle on the understanding of microplastic pollution and will drive data-based mitigation solutions.

Dr. Sheila Hemami
Senior Director Growth Initiatives at Triple Ring Technologies

 

My lab is especially interested in developing technologies that enable us to robustly count the number of microplastics in drinking water, ponds, lakes, and oceans. We need field-deployable sensors that provide us this information in order for us to understand microplastic pollution.

Dr. Anna Michel
Associate Scientist at Woods Hole Oceanographic Institution
A conceptual rendering of the at-home diagnostic device next to a bathroom sink.

At-Home Quantitative Diagnostics

Client

BARDA

Challenge

To address critical needs identified by the Biomedical Advanced Research and Development Authority (BARDA), Triple Ring was awarded a contract to design, build, and test a low-cost multiplexed quantitative biomarker detection platform for lab-at-home and low resource settings.

 

Outcomes

Triple Ring and a close collaborator, in a project funded by the Biomedical Advanced Research and Development Authority (BARDA), have developed a low-cost, user-centric, diagnostics platform for multiplexed quantitative biomarker measurements in patient samples. This novel platform was designed for use in CLIA-waived in vitro diagnostic settings and is notable for its low manufacturing cost. The platform supports lab-at-home, point of care (POC), and direct to consumer workflows especially in low-resource settings. Triple Ring’s consolidated expertise across biological, electrical, embedded software, mechanical, and optical systems enabled a robust design capable of quantifying biomarker concentrations from multiplexed lateral flow immunoassay (LFA) test strips. Additionally, the system was demonstrated to extend the quantitative measurement range beyond that of typical lateral flow assay readers. Currently, the team is performing systems integration and testing for a handheld version of the diagnostic device.

 

Triple Ring Value Proposition

  • Multidisciplinary team including biochemistry, assay development, biology, computer science, optics, and multiple engineering disciplines to design, build, and test complex systems with very low manufacturing costs
  • Focus on building transformational platforms and capabilities to target unmet needs in the in vitro diagnostics space, including development for low-resource and remote settings
  • Valuable IP creation
  • Company formation services through General Inception venture studio
An isolated conceptual 3D rendering of the at-home diagnostic device next to a cup with blue liquid
Illustration showing two steps: 1) A test strip is dipped into a liquid in a cup. 2) The strip is inserted into a small, rectangular digital device.

It’s very rewarding to work with our collaborators to develop new diagnostic tools to help protect the health of some of the most vulnerable populations around the world.

Dr. Rachel Gerver
Director of Systems Engineering, Triple Ring Technologies
A person holding a transdermal patch applicator

Microneedle Patch Applicator

Client

Confidential

Challenge

The client had developed a novel microneedle patch for transdermal drug delivery intended for use by the patient at home. The patch required a significantly greater degree of uniformity in pressure during application than existing transdermal patches. It required design of a reusable applicator to achieve reliable adhesion and dosing, while supporting the robustness and ruggedness requirements for use by a patient in their home and a low cost.

The key was ensuring that the patch would work across a wide variety of skin types in the potential patient population. Triple Ring relied on its expertise in material design and selection, precision mechanical engineering, and our life scientists to design an applicator that provided the required pressure for patch adhesion, across skin types that varied by thickness, age, moisture content, and placement.

 

Outcomes

The resulting single-entity combination product comprised a reusable applicator and a microneedle array containing patch, for intracutaneous drug delivery allowing rapid absorption into the bloodstream. With the applicator, the client was able to successfully enter clinical trials. Ultimately the technology for the product was acquired by a vaccine manufacturer.

 

Value Propositions

Triple Ring’s interdisciplinary team had all the required skills for a complex design.

3D view of an innovative commination medical device microneedle patch applicator for transdermal drug delivery. White and orange ergonomic handheld device with attachment
Diagram of a transdermal patch delivering medication through the skin with drug-coated tips penetrating the epidermis.

Background

The client was a publicly traded company with deep medical and domain expertise to address a drug delivery problem using their novel patch technology. They selected Triple Ring to design the mechanical delivery device based upon our long history of working with designing novel technologies for health care that delivered excellent user experiences. The Triple Ring designed applicator allowed the client to both more easily demonstrate their technology to other health care professionals and to get it into the hands of end users in clinical trials.

A four-panel illustration showing the steps for using a handheld transdermal patch applicator: from resting position, opening, applying on skin, to pressing the dispenser button.